Search research articles
Contact Us
Filters
Showing results (81-90 of 133) with videos related to
Page
of 14
Sort By:
Medrxiv : the Preprint Server for Health Sciences
|
November 14, 2023
Acute myeloid leukemia with mixed phenotype is characterized by <i>RUNX1</i> mutations, stemness features and limited lineage plasticity
Pallavi Galera, Deepika Dilip, Andriy Derkach, et al.
Science Advances
|
September 20, 2023
Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia
Troy M Robinson, Robert L Bowman, Sonali Persaud, et al.
American Journal of Hematology
|
August 18, 2018
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations
Xiaoli Mi, Gabriel Griffin, Winston Lee, et al.
Blood
|
April 14, 2021
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
Kitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2024
Multiplexed Spatial Profiling of Hodgkin Reed-Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Maryam Pourmaleki, Caitlin J Jones, Sabrina D Mellinghoff, et al.
Blood Advances
|
May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
Natasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2009
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells
Stephen J Salipante, Matthew E Mealiffe, Jeremy Wechsler, et al.
Blood Advances
|
June 27, 2020
Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
Brian J Ball, Christopher A Famulare, Eytan M Stein, et al.
Blood
|
January 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
Pallavi Galera, Deepika Dilip, Andriy Derkach, et al.
The Journal of Molecular Diagnostics : JMD
|
December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms
Ying Liu, Caleb Ho, Wayne Yu, et al.
Page
of 14
Search research articles
Search
Showing results (81-90 of 133) with videos related to
Sort By:
Page
of 14
Medrxiv : the Preprint Server for Health Sciences
|
November 14, 2023
Acute myeloid leukemia with mixed phenotype is characterized by <i>RUNX1</i> mutations, stemness features and limited lineage plasticity
Pallavi Galera, Deepika Dilip, Andriy Derkach, et al.
Science Advances
|
September 20, 2023
Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia
Troy M Robinson, Robert L Bowman, Sonali Persaud, et al.
American Journal of Hematology
|
August 18, 2018
Genomic and clinical characterization of B/T mixed phenotype acute leukemia reveals recurrent features and T-ALL like mutations
Xiaoli Mi, Gabriel Griffin, Winston Lee, et al.
Blood
|
April 14, 2021
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapy
Kitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 1, 2024
Multiplexed Spatial Profiling of Hodgkin Reed-Sternberg Cell Neighborhoods in Classic Hodgkin Lymphoma
Maryam Pourmaleki, Caitlin J Jones, Sabrina D Mellinghoff, et al.
Blood Advances
|
May 23, 2020
Clonal hematopoiesis in angioimmunoblastic T-cell lymphoma with divergent evolution to myeloid neoplasms
Natasha E Lewis, Kseniya Petrova-Drus, Sarah Huet, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
August 27, 2009
Mutations in a gene encoding a midbody kelch protein in familial and sporadic classical Hodgkin lymphoma lead to binucleated cells
Stephen J Salipante, Matthew E Mealiffe, Jeremy Wechsler, et al.
Blood Advances
|
June 27, 2020
Venetoclax and hypomethylating agents (HMAs) induce high response rates in MDS, including patients after HMA therapy failure
Brian J Ball, Christopher A Famulare, Eytan M Stein, et al.
Blood
|
January 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype
Pallavi Galera, Deepika Dilip, Andriy Derkach, et al.
The Journal of Molecular Diagnostics : JMD
|
December 16, 2023
Quantification of Measurable Residual Disease Detection by Next-Generation Sequencing-Based Clonality Testing in B-Cell and Plasma Cell Neoplasms
Ying Liu, Caleb Ho, Wayne Yu, et al.
Page
of 14